We use cookies on our website. Carry on browsing if you’re happy with this or find out more

Our vision

Global, inspirational, novel

With private financing from Wellcome Trust, Bill & Melinda Gates Foundation, Woodford Patient Capital Trust plc, Malin Corporation plc, ORI Fund and Hepalink, we can create a mature and long-term vision for success in tackling some of the most challenging diseases.

Our vision is to be a global biopharmaceutical company, an inspirational home of molecular immunology driving the development of novel drug substances.

Our mission

Fusing passion with compassion, Kymab’s mission is:

  • To realise fully the value of antibodies developed using our discovery and development platforms
  • To deliver modern medicines on unique and proven platforms
  • To bring hope to patients with high unmet needs
  • To treat the world’s diseases, bringing societal benefit
  • To be an effective global partner in ameliorating global disease
  • To realise unique opportunities for partners and value for investors from our unique approach

We discover and develop antibody therapeutics to build a strong portfolio of assets

View our pipeline